MagQu Carcinoembryonic Antigen (CEA) Magnetic Reagent - Taiwan Registration 869e459c067c7de0c3dbd7baa5ed394d
Access comprehensive regulatory information for MagQu Carcinoembryonic Antigen (CEA) Magnetic Reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 869e459c067c7de0c3dbd7baa5ed394d and manufactured by MAGQU CO., LTD.. The authorized representative in Taiwan is MAGQU CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
869e459c067c7de0c3dbd7baa5ed394d
Ministry of Health Medical Device Manufacturing No. 005625
Product Details
This product is used to quantify the concentration of carcinoembryonic antigen (CEA) protein in human serum and needs to be used with a magnetic immunoassay analyzer (XacPro-E series); it can be used to help monitor changes in human serum CEA concentration.
C Immunology and microbiology devices
C6010 Tumor-associated antigen immunoassay system
Produced in Taiwan, China
Dates and Status
Jul 10, 2017
Jul 10, 2022